Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-19

Clinical Trial Update: Changing Diabetes® World Tour

View source ↗

Summary

The ClinicalTrials.gov study NCT01437072 sponsored by Novo Nordisk A/S has completed. It relates to diabetes mellitus type 1 and type 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED